Ex-vivo response to blood products and haemostatic agents after paediatric cardiac surgery

Keyphrases

• Blood Products 100%
• Hemostatic Agents 100%
• Coagulation Profile 100%
• Pediatric Cardiac Surgery 100%
• Cardiac Surgery 33%
• After Surgery 33%
• Coagulopathy 33%
• Hemostatic Potential 33%
• Recombinant Activated Factor VII (rFVIIa) 33%
• Rotational Thromboelastometry (ROTEM) 33%
• Clot 33%
• Volume Overload 33%
• Bleeding Complications 33%
• Tranexamic Acid 33%
• Thromboelastometry 33%
• Fibrinogen Concentrate 33%
• Fresh Frozen Plasma 33%
• Clotting Time 33%
• Haemostatic Intervention 33%
• Complications after Cardiac Surgery 33%
• Pooled Platelets 33%
• Factor Concentrates 33%

Medicine and Dentistry

• Heart Surgery 100%
• Blood Product 100%
• Hemostat 100%
• Ex Vivo 100%
• Pediatrics 100%
• Bleeding 20%
• Coagulopathy 20%
• Platelet 20%
• Thromboelastometry 20%
• Volume Overload 20%
• Tranexamic Acid 20%
• Recombinant Blood Clotting Factor 7a 20%
• Fibrinogen Concentrate 20%
• Fresh Frozen Plasma 20%
• Factor XIII 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Hemostatic Agent 100%
• Bleeding 20%
• Blood Clotting Disorder 20%
• Recombinant Blood Clotting Factor 7a 20%
• Tranexamic Acid 20%
• Blood Clotting Factor 13 20%
• Fibrinogen Concentrate 20%
• Clotting Time 20%
• Fresh Frozen Plasma 20%